Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0021218067
Tue, 28.03.2023
Evolva Holding SA
Evolva Holding SA
/ Key word(s): Product Launch
Evolva goes Responsible Care at in-cosmetics 2023
28.03.2023 / 07:00 CET/CEST
Press Release (PDF)
PRESS RELEASE
Evolva is globally launching an exclusive line of nature-based high-purity ingredients and bio-functionals for the personal care industry, produced in a sustainable mann [ … ]
Fri, 24.03.2023
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Board of Directors proposes, among others, the following to the shareholders:
Reverse stock split of 250:1, followed by a reduction of the nominal value of the shares to CHF 1.00
Introduction of a capital band of up to 20% of current share capital to give the B [ … ]
Fri, 24.03.2023
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Board of Directors proposes, among others, the following to the shareholders:
Reverse stock split of 250:1, followed by a reduction of the nominal value of the shares to CHF 1.00
Introduction of a capital band of up to 20% of current share capital to give the B [ … ]
Thu, 09.03.2023
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Reinach, 9 March 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, delivered a strong performance during 2022, fully meeting its targets. Total revenue increased by 57% (prior year +40%) to CHF 15.5 million, while produ [ … ]
Thu, 09.03.2023
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Reinach, 9 March 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, delivered a strong performance during 2022, fully meeting its targets. Total revenue increased by 57% (prior year +40%) to CHF 15.5 million, while produ [ … ]
Mon, 06.03.2023
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
By leveraging Evolva’s precision-fermentation technology, Grace Breeding’s Nitrogen Fixation solution has demonstrated the desired impact on yield and overall crop resilience
Reinach, Switzerland and Rehovot, Israel, 6 March 2023 — Evolva (SIX: EVE), a pio [ … ]
Mon, 06.03.2023
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
By leveraging Evolva’s precision-fermentation technology, Grace Breeding’s Nitrogen Fixation solution has demonstrated the desired impact on yield and overall crop resilience
Reinach, Switzerland and Rehovot, Israel, 6 March 2023 — Evolva (SIX: EVE), a pio [ … ]
Wed, 11.01.2023
Evolva Holding SA
Total revenues grew by 57% in 2022 to CHF 15.5 million
Gross contribution margin increased to around 21% in H2 2022 – after 10.9% in H1
For the full year 2022, gross contribution margin amounted to around 16%
For 2023, Evolva expects revenues of over CHF 20 million and a gross contribution margin of above 20%
Reinach, 11 January 2023 – Evolva ( [ … ]
Wed, 14.12.2022
Evolva Holding SA
Evolva Holding SA
/ Key word(s): Market launch
Evolva launches its Natural Nootkatone
14.12.2022 / 07:00 CET/CEST
Reinach, 14 December 2022 – Evolva (SIX: EVE) a pioneer in the field of natural molecules and industrial biotech, is lauching “Natural Nootkatone by Evolva”, a natural ingredient at the highest purity level now meeti [ … ]
Wed, 14.12.2022
Evolva Holding SA
Evolva Holding SA
/ Key word(s): Market launch
Evolva launches its Natural Nootkatone
14.12.2022 / 07:00 CET/CEST
Reinach, 14 December 2022 – Evolva (SIX: EVE) a pioneer in the field of natural molecules and industrial biotech, is lauching “Natural Nootkatone by Evolva”, a natural ingredient at the highest purity level now meeti [ … ]